Patent · US Expired

Antiviral combinations and compounds therefor

US5393883A · kind A · utility

3Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 1992
Grant dateFeb 28, 1995
Priority date
Expiry dateFeb 7, 2012

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel ribonucleotide reductase inhibitors and new combinations comprising an antiviral compound, such as acyclovir, and a thiocarbonohydrazone ribonucleotide reductase inhibitor for the chemotherapeutic treatment of virus infections, especially viruses of the herpes group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.